-
ILCA 2024 | Dr. Zilin Cui: Milan Criteria vs. Ontario Criteria—A UNOS Analysis
In clinical practice, several criteria are available for evaluating liver transplant candidates, such as the Milan Criteria, UCSF Criteria in the U.S., Ontario Criteria in Canada, and domestic standards like the Fudan Criteria and Hangzhou Criteria in China. Among these, the Milan Criteria are the most widely adopted. However, differences in survival outcomes based on…
-
Dr. Arnaud Pigneux: Sharing the Innovative Achievements of AML Treatment by the French Innovative Leukemia Organization (FILO)
Recently, the 11th Sino-French Hematology Academic Conference successfully took place in Tianjin, China, attracting hundreds of top authorities and scholars in the field of hematology from both domestic and international circles. During the conference, “Hematology Frontier” specially invited Dr. Arnaud Pigneux from Haut-Leveque Hospital, University of Bordeaux, to discuss the innovative practice achievements of the…
-
ESMO China Voice: Personalized ctDNA Methylation for Monitoring MRD Post-Liver Cancer Resection by Fan Jia, Jian Zhou & Xinrong Yang’s Team
The study design encompasses recruiting around 200 patients with hepatocellular carcinoma (HCC) who have undergone radical surgery, with a two-year follow-up. Samples of cancer tissue, adjacent tissue, and blood are…
-
Exclusive Interview with Dr. Xiaobing Chen: New Strategies for Early Screening and Immunotherapy in Esophageal Cancer
At the 2024 Chinese Anti-Cancer Association (CACA) Integration of Esophageal Cancer Academic Conference, Oncology Frontier invited Dr. Xiaobing Chen, Secondary Professor/Chief Physician at the Department of Internal Medicine at Henan Cancer Hospital and Chair of the CACA Esophageal Tumor Integrated Rehabilitation Committee, to provide an in-depth analysis of early signs of esophageal cancer, screening methods,…
-
Dr. Christian Chabannon: The Era of Personalized Immunotherapy from a European Perspective
Recently, the 11th Sino-French Hematology Academic Conference, organized by the Chinese Medical Doctor Association, was successfully held in Tianjin, China, attracting hundreds of top experts and scholars in the field of hematology from both China and abroad. During the conference, “Hematology Frontier” specially invited Dr. Christian Chabannon from the Paoli-Calmettes Institute in Marseille, France, to…
-
Dr. Frédéric Millot: Future Directions in the Treatment of Chronic Myeloid Leukemia (CML) in Children
Recently, the 11th Sino-French Hematology Academic Conference, organized by the Chinese Medical Doctor Association, was successfully held in Tianjin, attracting hundreds of top experts and scholars in the field of hematology from China and abroad. During the conference, Dr. Frédéric Millot from the University Hospital of Poitiers, France, was invited by “Hematology Frontier” to share…
-
Dr. Lanfang Li and Dr. Weiyun Zhuang Discuss Mycosis Fungoides and Sézary Syndrome
The 5th Tianjin International Lymphoma Academic Conference, serving as an academic platform to foster international academic exchange and cooperation, has actively played its role as a bridge, facilitating in-depth exchange and collaboration in the field of international lymphoma. During the conference, “Hematology Frontier” specially invited Dr. Lanfang Li from the Tianjin Medical University Cancer Institute…
-
Dr. Lihua Qiu and Dr. Swaminathan Iyer Discuss the Latest Advances and Optimal Strategies for Peripheral T-Cell Lymphoma Treatment
The 5th Tianjin International Lymphoma Academic Conference, serving as an academic platform to foster international academic exchange and cooperation, has actively played its role as a bridge, facilitating in-depth exchange and collaboration in the field of international lymphoma. During the conference, “Hematology Frontier” specially invited Dr. Lihua Qiu from Tianjin Medical University Cancer Institute and…
Connecting Medical Expertise through Media